Raymond James Biotech Innovation Summit: Checking in with Vera's Founder & CEO Marshall Fordyce ahead of the July 7 FDA decision date for the APRIL & BAFF targeting IgAN treatment Atacicept
He reminds us of the unmet need for this type of therapy and discusses the planning that Vera has been doing ahead of the decision date.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.